Su1114 A SHIFT IN PRESCRIBING PATTERNS OF ANTI-OBESITY MEDICATIONS – AN ASSESSMENT OF EVIDENCE-BASED PRACTICE IMPLEMENTATION
Leggi →
Maggio 2024
Risultati per: Scoperta una nuova molecola anti-cancro
Questo è quello che abbiamo trovato per te
Su1042 IMPROVING RATES OF PRE-PROCEDURAL DIAGNOSTIC WORKUP BEFORE ANTI-REFLUX PROCEDURES
Leggi →
Maggio 2024
771 CELL CYCLE REGULATION VIA P21 PATHWAY MEDIATES CD4+ T CELL EXHAUSTION DURING ANTI-TUMOR RESPONSE IN COLORECTAL CANCER
Leggi →
Maggio 2024
Sa1367 BOTH 14-DAY VONOPRAZAN TRIPLE THERAPY AND 14-DAY RABEPRAZOLE REVERSE HYBRID THERAPY ARE SUPERIOR TO 14-DAY VONOPRAZAN HIGH-DOSE DUAL THERAPY FOR THE FIRST-LINE ANTI-H. PYLORI TREATMENT IN POPULATION WITH HIGH RATES OF ANTIBIOTIC RESISTANCE
Leggi →
Maggio 2024
709 FUSOBACTERIUM NUCLEATUM FACILITATES ANTI-PD-1 THERAPY IN MICROSATELLITE STABLE COLORECTAL CANCER
Leggi →
Maggio 2024
Sa1463 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) REDUCE SEVERITY AND LENGTH OF STAY IN PATIENTS WITH ACUTE PANCREATITIS (AP): A SYSTEMATIC REVIEW AND META-ANALYSIS
Leggi →
Maggio 2024
789 CALY-002, AN ANTI-IL-15 ANTIBODY, PREVENTS GLUTEN CHALLENGEINDUCED MUCOSAL DAMAGE AND INFLAMMATION: RESULTS FROM A PHASE 1A/B STUDY
Leggi →
Maggio 2024
Sa1380 ANTI-INFLAMMATORY PROPERTIES OF FEXUPRAZAN VIA NF-κB INHIBITION AGAINST HELICOBACTER PYLORI CAGA-INDUCED INFLAMMATION
Leggi →
Maggio 2024
1161 CHARACTERIZING AND IDENTIFYING ANTI-INFLAMMATORY WHEAT ARABINOXYLAN-DERIVED BACTEROIDES INTESTINALIS METABOLITES TO TREAT INFLAMMATORY DISEASES
Leggi →
Maggio 2024
Mo1312 LYON CONSENSUS 2.0: ARE WE DEPRIVING PATIENTS OF EFFECTIVE ANTI-REFLUX MANAGEMENT?
Leggi →
Maggio 2024
858 G-CSF PROMOTES ANTI-TUMOR RESPONSE OF NK CELLS BY ACTIVATING GRANULOPOIESIS IN HEPATOBLASTOMA
Leggi →
Maggio 2024
Tu1250 ANTI-REFLUX MECHANISM OF DIAPHRAGMATIC BREATHING IN PATIENTS WITH REFLUX SYMPTOMS
Leggi →
Maggio 2024
Tu1098 IMPLICATIONS OF POPULAR TRENDING ANTI-OBESITY MEDICATIONS – AN INCREASE IN HEALTHCARE COST AND UTILIZATION FOR THE POPULATION WITH CONSTIPATION
Leggi →
Maggio 2024
Tu1031 LOW PRESCRIPTION RATES OF ANTI-OBESITY MEDICATIONS AND BARIATRIC SURGERY IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH OBESITY COMPARED TO THE GENERAL POPULATION WITH OBESITY DESPITE NEW EFFECTIVE GLUCAGON LIKE PEPTIDE 1 (GLP-1) AGONISTS
Leggi →
Maggio 2024
Mo1820 ANTI-TNF EXPOSURE IS ASSOCIATED WITH AN INCREASED RISK OF URGENT AND ONE-YEAR COLECTOMY IN ACUTE SEVERE ULCERATIVE COLITIS
Leggi →
Maggio 2024
Mo1950 COMPARATIVE EFFICACY OF ENDOSCOPIC SUBMUCOSAL DISSECTION AND ANTI-OBESITY MEDICATIONS IN MANAGING WEIGHT RECURRENCE POST-ROUX-EN-Y GASTRIC BYPASS VIA TRANSORAL OUTLET REDUCTION
Leggi →
Maggio 2024
